Skip to main content

Table 2 The mRNA level of ARHGAP11A correlated to clinicopathological variables in TCGA

From: Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma

Clinicopathological variables

ARHGAP11A mRNA expression

Total

P value

Low

High

Clinical grades

 G1/2

137

95

232

.000

 G3/4

47

87

134

Total

184

182

366

 

T Stage

 T1

106

75

181

.001

 T2

41

53

94

 T3/4

36

57

93

Total

183

185

368

 

Pathological Stage

 Stage I

99

72

171

.004

 Stage II

39

47

86

 Stage III/IV

36

54

90

Total

174

173

347

Â